Psychiatric research landscape analysis (March–June 2026)
Dataset: Psychiatric_3-6_2026_3.xlsx (N=298)
Psychiatric Meta-Landscape Report 2026
Scientific Psychiatric Analysis (March–June 2026)
A systematic computational review of 298 peer-reviewed publications across 39 high-impact journals. Revealing structural dynamics around neuromodulation, diagnostic AI, and global mental-health inequalities.
Journals Analyzed39 journals
Leading Key DomainNeuromodulation
Fastest GrowingClinical GenAI / ML
Depression Dominance
42.6%
Treatment & Depression-focused Interventions
Active Neuromodulation
94
Articles targeting rTMS, iTBS, and dTMS
Digital Health & AI
22.1%
App & chatbot trials (N=66)
Suicide: Burden in LMICs
77%
of suicides occur in low- and middle-income countries
Distribution of Key Research Themes
Publication Share of Top Journals
Section 1 — Thematic Landscape
Leading Research Domains
Breakdown across the 2026 active cohort's research categories (N=298)
Research such as the Canadian National Person-Context Network Analysis shows that biological factors and psychosocial dynamics continuously interact. The data mark a clear shift toward integrated multi-factor mapping.
Observational studies form the baseline, but the rapid rise of ML & Computational Modeling marks a qualitative leap. Cross-referencing functional neural-connectivity signatures with massive data cohorts is enabling unprecedented anticipation of therapeutic responsiveness.
Interactive AI Simulator
DMN Connectome Classifier
Predicts clinical response to escitalopram based on Default Mode Network (DMN) functional connectivity.
Weak Connection45%Strong Connection
Severe Stress (1)7.0Optimal Support (10)
Machine Learning Model Prediction
Estimated Clinical Response:Likely Responder
Confidence Level82%
Sensitivity Index0.89
Section 3 — Therapeutic Modalities
Exploring Intervention Modalities
Select a therapeutic modality to explore its publication prevalence, key mechanisms, and reference clinical studies.
Breakthrough: Muscle-Brain Axis
How Muscle Talks to the Brain
Published in Molecular Psychiatry 2026, researchers isolated the apelin protein as a direct mediator of exercise-induced antidepressant effects. This finding validates a new muscle-brain molecular axis.
A landmark trial in Translational Psychiatry shows that the magnitude of the acute placebo response strongly predicts long-term active-drug efficacy trajectories, confirming the neurobiological signature of therapeutic expectation.
77% of global suicides occur in low- and middle-income countries (LMICs), yet only a tiny fraction of research published in 2026 specifically targets these populations.
Multi-Country Survey
Suicidal Ideation Across 8 Countries
Sample of 27,786 individuals across Algeria, Azerbaijan, Eswatini, Guyana, Kiribati, Malawi, Tuvalu, and Zambia.
Emphasize implementation science to overcome the efficacy-effectiveness bottleneck. Integrate cross-cultural adaptations.
For Funders
Increase global mental-health funding by an order of magnitude and co-fund clinically validated applications.
For Clinicians
Adopt routine measurement-based-care protocols. Use network imaging and computational classifiers as diagnostic support.
AI Research Assistant
Query the full corpus of 298 psychiatric publications from 2026
Active Knowledge Base: N=298
AI Assistant
Hello! I'm your research assistant specialized on the Psychiatric_3-6_2026_3.xlsx database. I can help you find publications on neuromodulation (rTMS), DMN biomarkers, digital mental-health interventions, or the impact of global health inequalities. What would you like to analyze?
Active Psychiatric Literature Matrix
Search, filter, and explore in real time the 298 indexed publications in the active cohort